Biolux Technology, the developer of OrthoPulse, has announced a nationwide initiative to scale the adoption of its FDA-cleared device across group dental and orthodontic practices.
The company is focusing on strategic partnerships with leading dental support organizations (DSOs) and orthodontic support organizations (OSOs) to integrate OrthoPulse into clinical workflows.
OrthoPulse uses near-infrared light therapy, clinically shown to accelerate tooth movement, reduce discomfort, and support oral health, including periodontal improvement and post-treatment bone remodeling. The device is compatible with both aligner and bracket-based treatments.
Beyond the device, Biolux offers a digital platform that includes a patient app for daily usage tracking and automated reminders, as well as a doctor portal for real-time monitoring of patient progress and compliance.
This platform aims to ensure more predictable outcomes and enable early intervention when needed.
By collaborating with DSO and OSO procurement teams, Biolux is integrating OrthoPulse into bundled treatment offerings, improving revenue, case acceptance, and workflow efficiency.
“We’re not just scaling a device—we’re scaling smarter orthodontics,” said Michael Hendricks, head of U.S. operations at Biolux Technology.
“Partnering with top DSOs and OSOs allows us to embed OrthoPulse into everyday workflows, enhancing patient outcomes and setting a new standard in orthodontic care.”
